JP Morgan Chase’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-418,060
| Closed | -$53.6M | – | 7402 |
|
|
2025
Q2 | $53.6M | Sell |
418,060
-2,088,454
| -83% | -$217M | ﹤0.01% | 1294 |
|
|
2025
Q1 | $222M | Buy |
2,506,514
+1,350,880
| +117% | +$132M | 0.02% | 643 |
|
|
2024
Q4 | $101M | Sell |
1,155,634
-66,418
| -5% | -$6.08M | 0.01% | 931 |
|
|
2024
Q3 | $113M | Sell |
1,222,052
-2,602
| -0.2% | -$258K | 0.01% | 894 |
|
|
2024
Q2 | $132M | Sell |
1,224,654
-86,718
| -7% | -$8.68M | 0.01% | 802 |
|
|
2024
Q1 | $124M | Sell |
1,311,372
-208,336
| -14% | -$17.9M | 0.01% | 842 |
|
|
2023
Q4 | $140M | Sell |
1,519,708
-174,509
| -10% | -$11.3M | 0.01% | 744 |
|
|
2023
Q3 | $85.1M | Buy |
1,694,217
+85,648
| +5% | +$4.58M | 0.01% | 875 |
|
|
2023
Q2 | $102M | Buy |
1,608,569
+56,813
| +4% | +$3.09M | 0.01% | 818 |
|
|
2023
Q1 | $69.8M | Buy |
1,551,756
+103,541
| +7% | +$4.66M | 0.01% | 946 |
|
|
2022
Q4 | $63.4M | Sell |
1,448,215
-42,419
| -3% | -$2.03M | 0.01% | 989 |
|
|
2022
Q3 | $98.2M | Sell |
1,490,634
-233,856
| -14% | -$15M | 0.02% | 738 |
|
|
2022
Q2 | $87.1M | Buy |
1,724,490
+49,366
| +3% | +$2.89M | 0.01% | 798 |
|
|
2022
Q1 | $107M | Buy |
1,675,124
+30,963
| +2% | +$2.22M | 0.01% | 809 |
|
|
2021
Q4 | $176M | Buy |
1,644,161
+126,350
| +8% | +$13.2M | 0.02% | 620 |
|
|
2021
Q3 | $156M | Sell |
1,517,811
-52,085
| -3% | -$4.85M | 0.02% | 668 |
|
|
2021
Q2 | $138M | Buy |
1,569,896
+32,553
| +2% | +$2.98M | 0.02% | 756 |
|
|
2021
Q1 | $149M | Buy |
1,537,343
+37,087
| +2% | +$3.7M | 0.02% | 675 |
|
|
2020
Q4 | $168M | Buy |
1,500,256
+133,544
| +10% | +$14.1M | 0.03% | 584 |
|
|
2020
Q3 | $125M | Buy |
1,366,712
+251,884
| +23% | +$19.4M | 0.02% | 621 |
|
|
2020
Q2 | $87M | Buy |
1,114,828
+145,063
| +15% | +$9.81M | 0.02% | 700 |
|
|
2020
Q1 | $56.7M | Buy |
969,765
+855,873
| +751% | +$55.1M | 0.01% | 760 |
|
|
2019
Q4 | $9.12M | Sell |
113,892
-7,666
| -6% | -$574K | ﹤0.01% | 2183 |
|
|
2019
Q3 | $8.93M | Buy |
121,558
+9,041
| +8% | +$782K | ﹤0.01% | 2221 |
|
|
2019
Q2 | $10.4M | Buy |
112,517
+1,143
| +1% | +$94.3K | ﹤0.01% | 2073 |
|
|
2019
Q1 | $8.91M | Buy |
111,374
+32,152
| +41% | +$2.38M | ﹤0.01% | 2155 |
|
|
2018
Q4 | $4.27M | Buy |
79,222
+2,211
| +3% | +$134K | ﹤0.01% | 2702 |
|
|
2018
Q3 | $6.01M | Buy |
77,011
+3,904
| +5% | +$271K | ﹤0.01% | 2588 |
|
|
2018
Q2 | $4.64M | Buy |
73,107
+20,349
| +39% | +$1.62M | ﹤0.01% | 2741 |
|
|
2018
Q1 | $4.84M | Buy |
52,758
+31,843
| +152% | +$2.74M | ﹤0.01% | 2606 |
|
|
2017
Q4 | $1.58M | Buy |
20,915
+9,639
| +85% | +$678K | ﹤0.01% | 3453 |
|
|
2017
Q3 | $772K | Buy |
11,276
+717
| +7% | +$38.3K | ﹤0.01% | 3642 |
|
|
2017
Q2 | $535K | Sell |
10,559
-134,166
| -93% | -$5.7M | ﹤0.01% | 3691 |
|
|
2017
Q1 | $5.79M | Sell |
144,725
-22,168
| -13% | -$794K | ﹤0.01% | 2335 |
|
|
2016
Q4 | $4.68M | Buy |
166,893
+2,168
| +1% | +$65.3K | ﹤0.01% | 2514 |
|
|
2016
Q3 | $4.89M | Buy |
164,725
+5,325
| +3% | +$132K | ﹤0.01% | 2274 |
|
|
2016
Q2 | $3.23M | Buy |
159,400
+79,225
| +99% | +$1.44M | ﹤0.01% | 2551 |
|
|
2016
Q1 | $1.45M | Buy |
80,175
+925
| +1% | +$16.1K | ﹤0.01% | 2875 |
|
|
2015
Q4 | $2.09M | Sell |
79,250
-12,273
| -13% | -$276K | ﹤0.01% | 2733 |
|
|
2015
Q3 | $1.95M | Sell |
91,523
-170,327
| -65% | -$4.71M | ﹤0.01% | 2762 |
|
|
2015
Q2 | $6.94M | Buy |
+261,850
| New | +$7.48M | ﹤0.01% | 2177 |
|
Other funds holding BPMC
IA
HNB